Insider trade

Huntington Bancshares (HBAN): Director bought ~$100K

John C Inglis, Director at Huntington Bancshares, bought ~$100K of Huntington Bancshares shares.

~$100K
Approx. value · 6,506 sh @ $15.30
90K
Holds after · shares reported
Traded
Nov 4, 2025
Filed
Nov 5, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Sep 5, 2025InsiderOfficer sold ~$740K of HBAN shares in the open market
  2. Sep 10, 2025Company filing · Form 8-K · Shareholder rights, Bylaws or charterChanged the rights of its shareholders, and changed its bylaws, charter or fiscal year (and 1 more item)
  3. Oct 17, 2025Company filing · Form 8-K · ResultsReported its results
  4. Oct 20, 2025Company filing · Form 8-K · Results, Other newsReported its results, and reported other company news
  5. Oct 26, 2025Company filing · Form 8-K · Material agreementSigned an important agreement
  6. Nov 4, 2025 · this disclosureInsider · First insider buy since May 2023Director purchased ~$100K of HBAN shares in the open market

What came next

  1. Nov 14, 2025InsiderOfficer sold ~$100K of HBAN shares in the open market
  2. Nov 21, 2025InsiderOfficer sold ~$993K of HBAN shares in the open market
  3. Nov 21, 2025CongressDisclosed sale of HBAN — reported range $100,001 - $250,000
  4. Dec 11, 2025Insider · 2 peopleInsiders: 2 sales (~$259K)
  5. Dec 12, 2025InsiderOfficer sold ~$44K of HBAN shares in the open market
  6. Jan 8, 2026InsiderOfficer sold ~$185K of HBAN shares in the open market
  7. Jan 22, 2026Company filing · Form 8-K · ResultsReported its results
  8. Feb 1, 2026Company filing · Form 8-K · Acquisition or sale, Shareholder rightsCompleted buying or selling a business or assets, and changed a top executive or board member (and 3 more items)“In accordance with the terms of the Merger Agreement, as of the Effective Time, the size of the board of directors of the Company (the “Board”) was increased to consist of a total of 15 directors, including the 12 directors of the Company as of immediately prior to the Effective Time and three former directors of Cadence.”
  9. Feb 4, 2026InsiderOfficer sold ~$112K of HBAN shares in the open market
  10. Feb 6, 20265% stakeBlackRock, Inc. reported a passive stake (13G) of 10.1%
  11. Feb 9, 20265% stakeSTATE STREET CORPORATION reported a passive stake (13G) of 4.9%
  12. Feb 10, 2026Insider · 1 personInsiders: 2 sales (~$330K)
  13. Feb 19, 2026Insider · First buy since 2023Director purchased ~$253K of HBAN shares in the open market
  14. Feb 27, 2026Insider · 1 personInsiders: 2 purchases (~$160K)
  15. Mar 2, 2026InsiderDirector purchased ~$11K of HBAN shares in the open market
  16. Mar 3, 2026InsiderDirector purchased ~$87K of HBAN shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Huntington Bancshares

For Huntington Bancshares, OQRO holds 5 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its HBAN page.

Other recent filings by John C Inglis, Director

The full history of John C Inglis, Director is on the profile page.

How this filing works

Explore the data

Other disclosures at Huntington Bancshares

Everything OQRO holds on this company is on its HBAN page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data